Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging of Glial Activation and Risk for Post-Traumatic Epilepsy
NCT03999164Phase 1Active, not recruiting
- Sponsor
- University of California, Davis
- Start
- Feb 2020
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of DPA-714 in traumatic brain injury (TBI), sponsored by University of California, Davis. Primary endpoint: Quantification of [18F]DPA-714 binding in the brain at 2 months. Started Feb 2020; status: active, not recruiting.
02
Drugs
DPA-714
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT03999164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03999164.